MW
D Oregon House · District 11

Rep. Marty Wilde

Contact Email
Compare
Total votes
2,291
all sessions
Attendance
96%
89 missed
Near the chamber average
With party
97%
of cast votes
Lower than 87% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
640
bills & resolutions
Higher than 94% of chamber peers
Committees
0
assignments
640 bills and resolutions

Sponsored bills

Total
640
Primary
145
Co-sponsor
495
This page
640
matching current filters
Co-sponsor HCR 22
In committee · Oregon House · Co-sponsor
Resolving that Legislative Assembly shall appropriate from General Fund to Department of Veterans' Affairs amount that is no less than amount appropriated in biennium beginning July 1, 2015, as adjusted.

Resolves that in each biennium, Legislative Assembly shall appropriate from General Fund to Department of Veterans' Affairs amount that is no less than amount appropriated from General Fund to Department of Veterans' Affairs in biennium beginning July 1, 2015, as adjusted.

In committee Jul 1, 2019 1 co-sponsor
Primary HB 3342
Passed · Oregon House · Lead sponsor
Relating to plant-based meals.

Requires certain medical and residential facilities ] hospitals and long term care facilities to make available to patients and residents plant-based meals when necessary to accommodate medical, religious, cultural or ethnic needs, preferences or requests . Requires Department of Corrections to make available to inmates plant-based meals any time meal is served .

Passed Jul 1, 2019 0 co-sponsors
Co-sponsor SB 872
In committee · Oregon Senate · Co-sponsor
Relating to the cost of prescription drugs.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of ] amount of money spent on patient assistance programs , and ] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager . Excludes proprietary information from disclosure on department's website. ] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs for small employer and individual health benefit plans to insurer's website. Requires 60-day advance notice to department and to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash ] retail price for drug is less than insured's cost-share ] out-of-pocket cost for drug using pharmacy benefit , insured may pay cash ] retail price and expense must be counted ] if requested by enrollee, insurer must count cost toward deductible or out-of-pocket maximum. Requires State Board of Pharmacy to prescribe by rule notice of enrollee's rights for distribution to pharmacy customers and to translate notice into multiple languages. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers ] report to Oregon Health Authority information regarding 50 most prescribed drugs and 50 most expensive drugs prescribed by provider . Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget ] annual gross receipts exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority ] specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires insurers to include with rate filing certified statement regarding insurers' use of rebates. Requires drug advertisement to disclose wholesale price of drug. ] Modifies responsibilities of Task Force on Fair Pricing of Prescription Drugs and requires report of findings, by September 15, 2020, to interim committees of Legislative Assembly related to health. Modifies reporting to department by insurers about costly drugs reimbursed by health benefit plans. Requires pharmaceutical manufacturers that register with State Board of Pharmacy to also register with department. Requires department to adopt registration fee based on reasonable cost to department to administer specified provisions.

In committee Jun 30, 2019 1 co-sponsor
Primary HB 2530
Signed into law · Oregon House · Lead sponsor
Relating to housing for veterans.

Requires persons who send or serve certain documents related to termination of tenancy, forcible entry or detainer , overdue loan payments for loans secured by residential real property ] and residential foreclosures to include certain information regarding assistance that may be available to veterans of armed forces. Directs Department of Veterans' Affairs and Housing and Community Services Department to jointly submit written report on veterans' housing programs to interim House committee related to veterans.

Signed into law Jun 21, 2019 0 co-sponsors
Co-sponsor SB 829
Signed into law · Oregon Senate · Co-sponsor
Relating to wine labeling; and prescribing an effective date.

Requires that, to extent provided by Oregon Liquor Control Commission rules, if appellation of origin on wine label is American viticultural area in Oregon that is in larger American viticultural area, label must also identify larger American viticultural area. Requires commission to make requirement applicable by rule within Willamette Valley viticultural area. Prohibits use of American viticultural area on wine label in manner resembling brand. Creates exception. Applies to wine labeled on or after January 1, 2023. Requires commission to appoint advisory committee. Sunsets advisory committee January 2, 2024. Requires commission to adopt rules establishing penalty schedule for labeling requirement. Requires adoption of initial rules in time to take effect January 1, 2023. Repeals rule adoption requirement January 2, 2024. Requires commission to report to interim committee of Legislative Assembly no later than September 15, 2020, regarding advisory committee recommendations and status of commission rule adoption proceedings. Takes effect on 91st day following adjournment sine die.

Signed into law Jun 21, 2019 1 co-sponsor
Showing 601 to 610 of 640 bills
Previous 1 60 61 62 64 Next